Neuros MedicalAnnouncement of TreatmentPhantom Limb Pain (PLP) neuromodulation products---AltiusApproved by the FDA for market launch.AltiusIndicated for the treatment of adult amputeesChronic Refractory Pain Following AmputationPhantom Limband residual lower limb pain.“The approval of Altius represents a significant advancement for lower-limb amputees who have suffered from chronic, debilitating pain for years, with mostly ineffective treatment options. We finally have a solution proven to reduce pain and improve quality of life, supported by the first rigorous randomized controlled trial conducted in this patient population.”---Leonardo Kapural Florida Atlantic University“FDA approval of Altius marks a significant milestone in the treatment of post-amputation pain. Clinicians and patients now have a clinically validated therapy that addresses the root cause of post-amputation pain using an innovative, on-demand, patient-controlled device, without the addiction risks associated with opioids. We thank the investigators and participants in the QUEST study for their perseverance amid numerous challenges, including the COVID-19 pandemic, in bringing Altius to the amputee community.”
---David Veino, President and Chief Executive Officer of Neuros Medical
Phantom Limb Pain (PLP) is the patient's subjective sensation that the amputated limb still exists, accompanied by pain of varying degrees and characteristics. This type of pain mostly occurs at the distal end of the residual limb and is one of the most common postoperative complications in amputees.Studies have shown that 65% of patients develop phantom limb pain (PLP) within one month after amputation, 82% will develop PLP within one year, and 87% will develop PLP in their lifetime.The pain is typically characterized as colicky, knife-like, or drilling in nature.etc., belong to chronic neuropathic pain. Long-term chronic pain seriously affects the function of the patient's residual limb after surgery and the quality of rehabilitation.Currently, forPhantom Limb Paintreatment options are very limited,Primarily treated with medicationas the main component(Medications include:Opioids and gabapentinoids). Long-term use of these medications by the patient not only provides inadequate pain relief, but alsoDrug dependence develops. This forces patients to endure the medication andThe Double Hit of Phantom Limb Pain.Neuros MedicalDeveloped Neurostimulation ProductsAltiusEffectively alleviates phantom limb pain.Neuros MedicalRegistration Clinical Trials Conducted ShowAltiusProvides immediate and sustained pain relief, reduces opioid use, and improves quality of life in patients with chronic post-amputation pain.
Altiusis a treatment for phantom limb pain following chronic amputationPainand neuromodulation products for residual limb pain.AltiusUseNeuros Medical's patent -- "On-Demand Bioelectronic Nerve Block”technology to target the source of pain, namely the affected peripheralNerve.AltiusConsists of an implantable pulse generator with an integrated rechargeable battery, cuff electrodes, and external devices (clinician programmer, patient controller, and charger).
- AltiusCapable of addressing pain at its source,
The pulse generator is implanted into the patient's body through surgery.The cuff electrode is implanted onto the nerve at the amputation site (peripheral nerves);- Provides Unique Bioelectrical Nerve Block
Transmit high-frequency bioelectrical signals to the target sensory nerves to block pain signals;Patients use the controller to initiate a 30-minute treatment session, allowing them to use it freely as needed.
Neuros Medicalis an innovative neuromodulation company, whose developedAltiusNeurostimulators can be used to treat chronic post-amputation pain (phantom limb pain and residual limb pain).
